Nat. Rev. Endocrinol. doi: /nrendo

Slides:

Advertisements

Similar presentations

Nat. Rev. Endocrinol. doi: /nrendo

Advertisements

Figure 2 Electromechanical properties of OIHPs

Figure 6 Selected examples of TERS applications in material systems

Figure 3 Childhood craniopharyngioma

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 2 Regions of Africa exposed to undernutrition

Figure 2 Pathophysiology of hyperglycaemia in T2DM

Nat. Rev. Cardiol. doi: /nrcardio

with undiagnosed diabetes mellitus by three diagnostic criteria

Figure 4 Amino acid structure of short-acting and long-acting insulins

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Monogenic forms of diabetes mellitus

Figure 5 MRI of childhood craniopharyngioma

Figure 1 The Beckwith–Wiedemann spectrum

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Circadian and ultradian fluctuations in corticosterone

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Biosimilar development process

Figure 1 Intensity-based loading options to increase bone strength

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Effects of irisin on glucose homeostasis

Figure 2 Switching of biologic agents and biosimilars

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Osteosarcoma epidemiology

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Challenges and opportunities of using omics in EDC research

Figure 1 Oestrogen biosynthesis and production sites in the body

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Pharmacokinetic action profiles of rapid-acting insulins

Figure 4 Tracheal endoscopy in two patients

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Serum levels of TSH and free T4 in a large series

Figure 3 Statistical approaches for the analysis of metabolomic data

Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 BMPs in brown and beige adipogenesis and function

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Exosomes mediate the systemic benefits of endurance exercise

Figure 3 Pharmacodynamic action profiles of long-acting insulins

Figure 5 Systems biological model of IBS

Figure 6 Joint morphogenesis

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Gut microbial gene content and development of T1DM

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Oxidative phosphorylation

How Omics Data Can Be Used in Nephrology

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Timeline of pancreatic islet transplantation

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Exercise enhances insulin sensitivity

Figure 3 Determination of the primary site

Figure 3 Global iodine status and mandatory salt iodization

Nat. Rev. Endocrinol. doi: /nrendo

Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.81 Figure 2 Role of omics in identifying molecular fingerprints in EDC research Figure 2 | Role of omics in identifying molecular fingerprints in EDC research. Schematic representation of the overall paradigm of using genomics, epigenomics, mitochondriomics and other omics technologies in endocrine-disrupting chemical (EDC) research to create unique molecular ‘fingerprints’ that represent personal exposure, dose, biological response and susceptibility to EDCs. Messerlian, C. et al. (2017) ‘Omics’ and endocrine-disrupting chemicals — new paths forward Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.81